Localized myxedema of thyroid disease

Journal of the American Academy of Dermatology

Volumn 68, Issue 6, 2013, Pages

  Brinster, Nooshin K ^a,b   Garrett, Algin B ^a   Kostopoulos, Tassia C ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEVOTHYROXINE; MUCIN; RADIOACTIVE IODINE;

ADULT; CASE REPORT; DISEASE DURATION; FEMALE; FIBROBLAST; FOOT DISEASE; GRAVES DISEASE; HAIR FOLLICLE; HUMAN; HUMAN TISSUE; LETTER; LOCALIZED MYXEDEMA; MEDICAL HISTORY; MYXEDEMA; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SKIN BIOPSY; TUMOR VOLUME;

EID: 84877793098     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.11.019     Document Type: Article

References (4)

1. V. Fatourechi Pretibial myxedema: pathophysiology and treatment options Am J Clin Dermatol 6 2005 295 309
2. C. Daumerie, M. Ludgate, S. Costagliola, and M. Many Evidence for thyrotropin receptor immunoreactivity in pretibial connective tissue from patients with thyroid-associated dermopathy Eur J Endocrinol 146 2002 35 38
3. R. Douglas, A. Gianoukakis, S. Kamat, and T. Smith Aberrant expression of the insulin-like growth factor-1 receptor by T cells from patients with Graves' disease may carry functional consequences for disease pathogenesis J Immunol 178 2007 3281 3287
4. T. Smith, L. Hegedus, and R. Douglas Role of insulin-like growth factor (IGF-1) pathway in the pathogenesis of Graves' orbitopathy Best Pract Res Clin Endocrinol Metab 26 2012 291 302